Ajanta Pharma Limited (AJANTPHARM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 350.43B |
| Enterprise Value | 351.98B |
| P/E Ratio | 38.9 |
| PEG Ratio | 1.75 |
| Price/Sales Ratio | 7.64 |
| Price/Book Ratio | 9.75 |
| Enterprise/Revenue | 7.64 |
| Enterprise/EBITDA | 26.86 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.2 |
| Operating Margin | 0.38 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.26 |
Income Statement
| Revenue | 54.53B |
| Revenue/Share | 462.33 |
| Gross Profit | 28.05B |
| EBITDA | 15.67B |
| Net Income | 10.56B |
| Diluted EPS | 84.53 |
Balance Sheet
| Total Cash | 6.65B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 362.35 |
Price History
| 52-Week Change | 37.38 |
| 52-Week High | 3,796 |
| 52-Week Low | 2,329.9 |
| Moving Average 50 Days | 3,493.05 |
| Moving Average 200 Days | 3,050.11 |
Statistics
| Average Volume | 107,966 |
| Shares Outstanding | 124.94M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 60 |
| Trailing Annual Dividend Yield | 1.7 |
| Payout Ratio | 0 |
| Last Split Factor | 3:2 |
| Last Split Date | June 22, 2022 |
AD
